Pediatric tube feeding sales will strengthen through 2036, anchored by standard pediatric enteral formulas at 55.0% of the product segment. Gastrointestinal disorders dominate applications with a 45.0% share and hospital pharmacies hold 60.0% of distribution. The market was valued at USD 1.80 billion in 2025 and USD 3.79 billion by 2036.